[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"current-user-roles":3,"user-subscription":3,"filing:c9ae5a9bc8be3d32d6302fef1ad69064700ceb37e65e981fcd082e89c842c354":4},null,["Reactive",5],{"id":6,"pdfUrl":7,"documentUrl":3,"politicianName":8,"politicianSlug":9,"politicianPhotoUrl":10,"filingDate":11,"filingType":12,"transactions":13,"updatedAt":98},"c9ae5a9bc8be3d32d6302fef1ad69064700ceb37e65e981fcd082e89c842c354","https:\u002F\u002Fdisclosures-clerk.house.gov\u002Fpublic_disc\u002Ffinancial-pdfs\u002F2025\u002F10074897.pdf","Jared Moskowitz","jared-moskowitz","https:\u002F\u002Fwww.congress.gov\u002Fimg\u002Fmember\u002Fm001217_200.jpg","2026-08-13","Annual Report",[14,23,27,32,37,41,46,51,57,60,65,68,73,77,80,83,86,90,93,95],{"asset":15,"ticker":16,"transactionType":17,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":22},"Morgan Stanley Active Assets (5) → Stryker Corporation Common Stock","SYK","P","2025-01-15","$1,001 - $15,000","New","Dependent Child","af0b5038-9788-48eb-905a-9902915e944a",{"asset":24,"ticker":25,"transactionType":17,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":26},"Morgan Stanley Active Assets (1) → AbbVie Inc. Common Stock","ABBV","d91255ba-7663-46c1-84fe-8f2ada8c2dc1",{"asset":28,"ticker":29,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":31},"Morgan Stanley Active Assets (6) → Abbott Laboratories Common Stock","ABT","S","933fe255-0015-4659-b69e-ac62d9e1f16a",{"asset":33,"ticker":34,"transactionType":17,"transactionDate":35,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":36},"Eagle Strategies Investment Account → iShares MSCI USA Quality Factor ETF","QUAL","2025-02-28","32fec2a3-3fd9-4806-83de-afd7890900fe",{"asset":38,"ticker":39,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":40},"Morgan Stanley Active Assets (6) → Merck & Company, Inc. Common Stock","MRK","028644d6-54b7-45a5-9366-8caba883f8a8",{"asset":42,"ticker":43,"transactionType":44,"transactionDate":35,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":45},"Eagle Strategies Investment Account → iShares Core S&P 500 ETF","IVV","S (partial)","3f06ec94-a786-4adf-a71d-744e75646aff",{"asset":47,"ticker":48,"transactionType":17,"transactionDate":49,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":50},"Morgan Stanley Active Assets (1) → NVIDIA Corporation - Common Stock","NVDA","2025-03-11","026ccac0-fd44-4c47-ba3e-97218a61d86f",{"asset":52,"ticker":53,"transactionType":17,"transactionDate":54,"notificationDate":3,"amount":19,"filingStatus":20,"details":55,"guid":56},"Betterment SEP IRA (SP) → iShares Core U.S. Aggregate Bond ETF","AGG","2025-07-03","Spouse","f0dbb527-c700-44ab-9678-2fd4adc916c9",{"asset":58,"ticker":39,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":59},"Morgan Stanley Active Assets (1) → Merck & Company, Inc. Common Stock","a50fdf97-11b1-4097-80ba-e94432d2efad",{"asset":61,"ticker":62,"transactionType":17,"transactionDate":63,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":64},"Eagle Strategies Investment Account → iShares A.I. Innovation and Tech Active ETF","BAI","2025-05-21","883032f7-0eb3-4b35-a01b-1cfbd85cf5ff",{"asset":52,"ticker":53,"transactionType":17,"transactionDate":66,"notificationDate":3,"amount":19,"filingStatus":20,"details":55,"guid":67},"2025-09-03","6e97dc68-fbad-46d3-9dfb-75dd578fc491",{"asset":69,"ticker":70,"transactionType":30,"transactionDate":49,"notificationDate":3,"amount":71,"filingStatus":20,"details":3,"guid":72},"Morgan Stanley Active Assets (1) → Broadcom Inc. - Common Stock","AVGO","$15,001 - $50,000","4e55cc51-1e19-4ab0-a64d-9c69a3d896ea",{"asset":74,"ticker":75,"transactionType":17,"transactionDate":35,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":76},"Eagle Strategies Investment Account → iShares Core MSCI Emerging Markets ETF","IEMG","b2a2cf95-e62b-4c7c-9fc0-44f425dc4812",{"asset":78,"ticker":39,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":79},"Morgan Stanley Active Assets (5) → Merck & Company, Inc. Common Stock","e866c10b-2b78-45cd-aff3-d578a27ccdae",{"asset":81,"ticker":29,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":82},"Morgan Stanley Active Assets (1) → Abbott Laboratories Common Stock","4a41869d-2129-478f-a720-bc10f7351214",{"asset":84,"ticker":16,"transactionType":17,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":85},"Morgan Stanley Active Assets (6) → Stryker Corporation Common Stock","fae76734-0e6f-4643-9c27-e8276c97aa09",{"asset":87,"ticker":88,"transactionType":17,"transactionDate":35,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":89},"Eagle Strategies Investment Account → iShares S&P 100 Fund","OEF","08edd922-788d-4516-bbcf-99d937b2e8b2",{"asset":91,"ticker":29,"transactionType":30,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":92},"Morgan Stanley Active Assets (5) → Abbott Laboratories Common Stock","997f7046-bc0b-437a-a1cf-ddcc93226394",{"asset":42,"ticker":43,"transactionType":44,"transactionDate":63,"notificationDate":3,"amount":19,"filingStatus":20,"details":3,"guid":94},"570ee67b-e1f8-4112-97e5-b90ac6504a4b",{"asset":96,"ticker":25,"transactionType":17,"transactionDate":18,"notificationDate":3,"amount":19,"filingStatus":20,"details":21,"guid":97},"Morgan Stanley Active Assets (5) → AbbVie Inc. Common Stock","0a75d1b9-4cb3-412b-b4c0-1bbaa2ad393d","2026-08-14T15:16:35.237Z"]